Results 31 to 40 of about 3,285,062 (216)
Ursodeoxycholic acid improves bilirubin but not albumin in primary biliary cirrhosis: further evidence for nonefficacy. [PDF]
BACKGROUND/AIM: In randomised controlled trials (RCTs) of ursodeoxycholic acid (UDCA), although serum bilirubin is frequently reduced, its effect on disease progression and mortality is unclear.
Burroughs, Andrew K +11 more
core +1 more source
Twenty-three patients with gallstones were treated with two dosage levels of ursodeoxycholic acid, 600 mg/day and 150 mg/day. Two to three months after the treatment, the molar percentage of cholesterol in bile significantly decreased (from 7.4 to 4.5 ...
I Makino, S Nakagawa
doaj +1 more source
Drug therapy of primary biliary diseases: classical and modern strategies [PDF]
Definition: Primary biliary cirrhosis (PBC) and primary sclerosing cholangitis (PSC) are both cholestatic liver diseases. A common feature of these disorders is the accumulation of bile acids in the liver and blood, presumably because of decreased ...
Leuschner, Ulrich +3 more
core +1 more source
Radioimmunoassay of ursodeoxycholic acid in serum.
A sensitivie and specific radioimmunoassay for the measurement of serum ursodeoxycholic acid has been developed. Ursodeoxycholic acid bound to bovine serum albumin was used as an antigen, and antiserum to this antigen was raised in the rabbit.
I Makino +4 more
doaj +1 more source
New analogs of ursodeoxycholic acid and 7-epicholic acid containing a 6 alpha-methyl group were synthesized, and their physico-chemical properties were studied and compared with those of their natural analogs.
A Roda +7 more
doaj +1 more source
Enzyme-linked immunoassay of ursodeoxycholic acid in serum.
A sensitive and specific enzyme-linked immunoassay for the measurement of ursodeoxycholic acid in human serum was developed. Ursodeoxycholic acid conjugated to alkaline phosphatase (from calf intestine) was used as a tracer.
S Ozaki +4 more
doaj +1 more source
Ursodeoxycholic acid and hepatic diseases
Ursodeoxycholic acid (UDCA) is a hydrophilic bile acid, a potent antioxidant, which is currently used as a «panacea» for drug treatment of wide range of hepatic diseases.
A. I. Khavkin, G. V. Volynets
core +1 more source
The formation of ursodeoxycholic acid from chenodeoxycholic acid and the role of 7-ketolithocholic acid as an intermediate in this biotransformation were studied in vitro in fecal incubations as well as in vivo in the human colon.
H Fromm, R P Sarva, F Bazzoli
doaj +1 more source
Effect of ursodeoxycholic acid and chenodeoxycholic acid on major histocompatibility complex class I gene expression. [PDF]
The original publication is available at springerlink.comWe investigated effect of ursodeoxycholic acid on major histocompatibility complex class I gene expression in cultured human hepatoma cells.
Makino, Y +6 more
core +1 more source
We examined by titration the electrochemical properties, apparent pK (pK'a), precipitation pH, and undissociated bile acid solubilities of chenodeoxycholic acid and its 7 beta epimer, ursodeoxycholic acid and their glycine conjugates as functions of a ...
H Igimi, M C Carey
doaj +1 more source

